CY1111379T1 - Συνθεσεις και μεθοδοι για τη θεραπευτικη αντιμετωπιση πρωτογενων και μεταστατικων-νεοπλασματικων ασθενειων με τη χρηση τριοξειδιου του αρσενικου - Google Patents
Συνθεσεις και μεθοδοι για τη θεραπευτικη αντιμετωπιση πρωτογενων και μεταστατικων-νεοπλασματικων ασθενειων με τη χρηση τριοξειδιου του αρσενικουInfo
- Publication number
- CY1111379T1 CY1111379T1 CY20111100361T CY111100361T CY1111379T1 CY 1111379 T1 CY1111379 T1 CY 1111379T1 CY 20111100361 T CY20111100361 T CY 20111100361T CY 111100361 T CY111100361 T CY 111100361T CY 1111379 T1 CY1111379 T1 CY 1111379T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- compositions
- methods
- therapeutic
- therapeutic treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Η εφεύρεση αναφέρεται στη χρήση τριοξειδίου του αρσενικού για τη θεραπευτική αντιμετώπιση ενός συμπαγούς όγκου που επιλέγεται από την ομάδα που αποτελείται από καρκίνο στον μαστό, κόλον, ωοθήκες, νεφρά, κύστη, προστάτη και πνεύμονα.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6237597P | 1997-10-15 | 1997-10-15 | |
EP08016665A EP2018858B1 (en) | 1997-10-15 | 1998-10-15 | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic trioxide |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1111379T1 true CY1111379T1 (el) | 2015-08-05 |
Family
ID=22042073
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081101031T CY1108363T1 (el) | 1997-10-15 | 2008-09-24 | Φαρμακευτικες συνθεσεις που περιλαμβανουν τριοξειδιο αρσενικου για την θεραπεια του μη-hodgkin λεμφωματος |
CY20081101395T CY1110055T1 (el) | 1997-10-15 | 2008-12-02 | Φαρμακευτικες συνθεσεις που περιλαμβανουν τριοξειδιο αρσενικου για την θεραπεια του πολλαπλου μυελωματος |
CY20081101430T CY1110057T1 (el) | 1997-10-15 | 2008-12-10 | Φαρμακευτικες συνθεσεις που περιλαμβανουν τριοξειδιο αρσενικου για την θεραπεια ενος ογκου του κεντρικου νευρικου συστηματος |
CY20111100361T CY1111379T1 (el) | 1997-10-15 | 2011-04-05 | Συνθεσεις και μεθοδοι για τη θεραπευτικη αντιμετωπιση πρωτογενων και μεταστατικων-νεοπλασματικων ασθενειων με τη χρηση τριοξειδιου του αρσενικου |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081101031T CY1108363T1 (el) | 1997-10-15 | 2008-09-24 | Φαρμακευτικες συνθεσεις που περιλαμβανουν τριοξειδιο αρσενικου για την θεραπεια του μη-hodgkin λεμφωματος |
CY20081101395T CY1110055T1 (el) | 1997-10-15 | 2008-12-02 | Φαρμακευτικες συνθεσεις που περιλαμβανουν τριοξειδιο αρσενικου για την θεραπεια του πολλαπλου μυελωματος |
CY20081101430T CY1110057T1 (el) | 1997-10-15 | 2008-12-10 | Φαρμακευτικες συνθεσεις που περιλαμβανουν τριοξειδιο αρσενικου για την θεραπεια ενος ογκου του κεντρικου νευρικου συστηματος |
Country Status (21)
Country | Link |
---|---|
US (9) | US6875451B2 (el) |
EP (9) | EP1378241A1 (el) |
JP (1) | JP2001519366A (el) |
KR (1) | KR20010015755A (el) |
CN (1) | CN1282218A (el) |
AT (4) | ATE407683T1 (el) |
AU (1) | AU751932B2 (el) |
BR (1) | BR9813085A (el) |
CA (1) | CA2307208A1 (el) |
CY (4) | CY1108363T1 (el) |
DE (4) | DE69839682D1 (el) |
DK (4) | DK1391206T3 (el) |
ES (4) | ES2312701T3 (el) |
HK (3) | HK1061199A1 (el) |
IL (1) | IL135620A0 (el) |
NO (1) | NO20001977L (el) |
NZ (1) | NZ503973A (el) |
PL (1) | PL339909A1 (el) |
PT (4) | PT2018858E (el) |
TR (1) | TR200001959T2 (el) |
WO (1) | WO1999018798A1 (el) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1964557B1 (en) * | 1997-11-10 | 2013-01-02 | Memorial Sloan-Kettering Cancer Center | Process for producing arsenic trioxide formulations |
CN1233476A (zh) * | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
AUPQ296799A0 (en) | 1999-09-20 | 1999-10-14 | Unisearch Limited | A cell-membrane impermeable trivalent organoarsenical derivative and use thereof |
AUPR379801A0 (en) | 2001-03-19 | 2001-04-12 | Unisearch Limited | Use of a substantially cell membrane impermeable compound for treating arthritis |
US6680306B2 (en) * | 2001-06-21 | 2004-01-20 | Glycogenesys, Inc. | Method for enhancing the effectiveness of cancer therapies |
DE10196619D2 (en) * | 2001-07-05 | 2004-05-06 | Hans-Werner Luedke | Nahrungsergänzungsprodukt oder arzneimittel gegen bestimmte mangelzustände und hirnfunktionsstörungen |
AUPR874601A0 (en) * | 2001-11-08 | 2001-11-29 | Unisearch Limited | Selective targeting of apoptotic cells |
KR20030058019A (ko) * | 2001-12-29 | 2003-07-07 | 한국원자력연구소 | 삼산화비소(As₂O₃)를 유효 성분으로 포함하는 방사선치료증진제 |
WO2003057012A2 (en) * | 2002-01-07 | 2003-07-17 | Board Of Regents, The University Of Texas System | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
WO2003086424A1 (en) * | 2002-04-10 | 2003-10-23 | Korea Microbiological Laboratories, Ltd. | Pharmaceutical composition comprising arsenite for the treatment of malignancy |
US8394422B2 (en) * | 2002-04-26 | 2013-03-12 | Centre National De La Recherche Scientifique (Cnrs) | Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans |
FR2838965B1 (fr) | 2002-04-26 | 2004-06-25 | Centre Nat Rech Scient | Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme |
KR100492940B1 (ko) * | 2002-05-27 | 2005-06-02 | 김종배 | 항종양활성 증진용 조성물 |
US8906422B2 (en) * | 2002-10-09 | 2014-12-09 | The University Of Hong Kong | Method for inhibiting cancer using arsenic trioxide |
US20080089949A1 (en) * | 2006-10-13 | 2008-04-17 | Yok-Lam Kwong | Method for treating cancer using oral arsenic trioxide |
US20080166425A1 (en) * | 2002-10-09 | 2008-07-10 | The University Of Hong Kong | Method for inhibiting cancer using arsenic trioxide |
US7521071B2 (en) * | 2002-10-09 | 2009-04-21 | Versitech Limited | Formulation of oral compositions comprising arsenic trioxide and methods of use thereof |
ES2330519T3 (es) | 2002-11-07 | 2009-12-11 | Newsouth Innovations Pty Limited | Inducion de la transicion de permeabilidad mitocondrial. |
US20050053664A1 (en) | 2003-09-08 | 2005-03-10 | Eliezer Zomer | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
WO2005062810A2 (en) * | 2003-12-18 | 2005-07-14 | Mediscovery, Llc | Treatment of primary and metastatic neoplastic diseases with tetraarsenic decaoxide |
BRPI0508382A (pt) * | 2004-03-01 | 2007-07-31 | Peptimmune Inc | métodos e composições para tratamento de doenças auto-imunes |
US20050196464A1 (en) * | 2004-03-03 | 2005-09-08 | Tty Biopharm Company Limited | Method and pharmaceutical composition for treatment of skin neoplasm |
US20050208149A1 (en) * | 2004-03-18 | 2005-09-22 | Tty Biopharm Limited Company | Use of arsenic-containing pharmaceutical composition in combination with radiation therapy for cancer treatment |
US7655221B2 (en) * | 2004-05-07 | 2010-02-02 | Peptimmune, Inc. | Methods of treating disease with random copolymers |
US20060194725A1 (en) * | 2004-05-07 | 2006-08-31 | James Rasmussen | Methods of treating disease with random copolymers |
US20060003966A1 (en) | 2004-06-16 | 2006-01-05 | Jack Arbiser | Carbazole formulations for the treatment of psoriasis and angiogenesis |
TW201440760A (zh) * | 2004-07-16 | 2014-11-01 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
WO2006024489A2 (en) * | 2004-08-30 | 2006-03-09 | Interstitial Therapeutics | Methods and compositions for the treatment of cell proliferation |
WO2006102439A2 (en) | 2005-03-23 | 2006-09-28 | Florida Atlantic University | Treatment or prevention of cancer and precancerous disorders |
EP1721615A1 (en) * | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
US7968738B2 (en) | 2005-07-29 | 2011-06-28 | Ziopharm Oncology, Inc. | Compounds and methods for the treatment of cancer |
US20110020434A1 (en) * | 2005-09-02 | 2011-01-27 | O'halloran Thomas V | Nanoparticle arsenic-platinum compositions |
WO2007028154A2 (en) * | 2005-09-02 | 2007-03-08 | Northwestern University | Encapsulated arsenic drugs |
US8784899B2 (en) * | 2005-10-04 | 2014-07-22 | Samuel Waxman Cancer Research Foundation | Compositions and methods for cancer treatment |
US20080233207A1 (en) * | 2006-01-04 | 2008-09-25 | Sheptovitsky Yelena G | Injectable and Infusable Mercury Compositions and Methods for Treating Cancer |
ITMI20060480A1 (it) * | 2006-03-16 | 2007-09-17 | Solvay Solexis Spa | Usom di perfluoropolimeri nella dtermibnazione della costante di legame recettore-ligando |
US20090018142A9 (en) * | 2006-05-02 | 2009-01-15 | Zhengping Zhuang | Use of phosphatases to treat tumors overexpressing N-CoR |
TW200829261A (en) * | 2006-09-29 | 2008-07-16 | Ziopharm Oncology Inc | Method for controlling angiogenesis in animals |
US20080089951A1 (en) * | 2006-10-11 | 2008-04-17 | The University Of Hong Kong | Method for Inhibiting Cancer Using Arsenic Trioxide |
EP2069371B1 (en) | 2006-11-01 | 2013-03-13 | NewSouth Innovations Pty Limited | Organo-arsenoxide compounds and use thereof |
US8945505B2 (en) | 2007-02-02 | 2015-02-03 | Panaphix, Inc. | Use of arsenic compounds for treatment of pain and inflammation |
CN103788108B (zh) | 2007-02-06 | 2017-04-12 | 利克斯特生物技术公司 | 氧杂双环庚烷和氧杂双环庚烯,它们的制备及用途 |
CA2718472A1 (en) * | 2007-08-03 | 2009-02-12 | Lixte Biotechnology, Inc. | Use of phosphatases to treat neuroblastomas and medulloblastomas |
WO2009045440A1 (en) | 2007-10-01 | 2009-04-09 | Lixte Biotechnology Holdings, Inc. | Hdac inhibitors |
ES2392737T3 (es) * | 2007-11-02 | 2012-12-13 | Ziopharm Oncology, Inc. | Terapia combinada con compuestos arsenicales orgánicos |
BRPI0821002A2 (pt) * | 2007-12-12 | 2015-06-16 | Ziopharm Oncology Inc | Compostos e métodos para o tratamento de câncer |
US20090246291A1 (en) * | 2008-03-27 | 2009-10-01 | Angelika Burger | Method and compositions for treatment of cancer |
US8227473B2 (en) | 2008-08-01 | 2012-07-24 | Lixte Biotechnology, Inc. | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
WO2010147612A1 (en) | 2009-06-18 | 2010-12-23 | Lixte Biotechnology, Inc. | Methods of modulating cell regulation by inhibiting p53 |
WO2010014141A1 (en) * | 2008-08-01 | 2010-02-04 | Lixte Biotechnology, Inc. | Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase |
AU2009277086B2 (en) * | 2008-08-01 | 2015-12-10 | Lixte Biotechnology, Inc. | Neuroprotective agents for the prevention and treatment of neurodegenerative diseases |
DK3388111T3 (da) | 2008-08-20 | 2021-12-06 | Solasia Pharma K K | Organoarsenforbindelse til behandlingen af kræft |
KR101100786B1 (ko) * | 2008-12-16 | 2011-12-29 | (주)천지산 | 암에 대한 방사선 치료 증진용 조성물 |
TR201905548T4 (tr) * | 2009-09-10 | 2019-05-21 | Kominox Inc | Kanser kök hücresi hedefli ve ilaç dirençli kanser terapisi. |
IN2012DN02195A (el) * | 2009-09-18 | 2015-08-21 | Kominox Inc | |
US20120015023A1 (en) * | 2010-04-15 | 2012-01-19 | Antimisiaris Sophia G | Treatment of tumors prostate with arsonoliposomes |
US20160184356A1 (en) * | 2013-03-15 | 2016-06-30 | Ke Jian Jim Liu | Arsenic-based treatment of cancers and inflammatory disorders |
US20160015743A1 (en) * | 2013-03-15 | 2016-01-21 | Rush University Medical Center | Methods for treating cancer |
AU2014251087B2 (en) | 2013-04-09 | 2019-05-02 | Lixte Biotechnology, Inc. | Formulations of oxabicycloheptanes and oxabicycloheptenes |
FR3004949B1 (fr) * | 2013-04-26 | 2016-02-05 | Centre Nat Rech Scient | Traitement de maladies autoimmunes et inflammatoires par les composes de l'arsenic as203 et/ou as205 administres par voie locale |
US9700580B1 (en) | 2016-06-14 | 2017-07-11 | Marguerite Harning | Method for cancer treatment |
MX2019006107A (es) | 2016-12-01 | 2019-08-21 | Eupharma Pty Ltd | Composiciones de arsenico. |
KR101844050B1 (ko) * | 2016-12-09 | 2018-05-14 | 주식회사 케마스 | 육산화사비소의 결정다형을 포함하는 암 예방 또는 치료용 약학 조성물 |
WO2018209343A1 (en) * | 2017-05-12 | 2018-11-15 | Rajur Sharanappa Basappa | Novel methods, compounds, and compositions: small molecule anticancer agents |
WO2019234112A1 (en) | 2018-06-05 | 2019-12-12 | Katholieke Universiteit Leuven | Combination treatment of arsenic oxide and antiandrogens |
CN112675197A (zh) * | 2021-01-22 | 2021-04-20 | 中山大学孙逸仙纪念医院 | 一种用于儿童Hedgehog信号通路驱动肿瘤的药物组合物 |
CN114028425A (zh) * | 2021-09-24 | 2022-02-11 | 上海交通大学医学院附属新华医院 | 硫化砷及其与放疗联合在治疗横纹肌肉瘤上的应用 |
CN115634287A (zh) * | 2022-09-30 | 2023-01-24 | 苏州系统医学研究所 | 一种基于砷化合物的肿瘤疫苗及其制备方法和应用 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US132275A (en) | 1872-10-15 | Improvement in medical compounds | ||
US232807A (en) | 1880-10-05 | Herbert e | ||
US3700498A (en) | 1970-12-10 | 1972-10-24 | Ibm | Process for making electrophotographic plates |
JPS5188620A (en) | 1975-01-31 | 1976-08-03 | Jintainokenkonoiji kotonigannitaishitekonoojusuru noshukuionekinoseizoho | |
DE3003635C2 (de) | 1980-02-01 | 1985-07-11 | Klöckner-Humboldt-Deutz AG, 5000 Köln | Verfahren und Vorrichtung zur Entarsenierung arsenhaltiger Materialien |
US4599305A (en) * | 1984-07-16 | 1986-07-08 | The Regents Of The University Of California | Method and composition for detection of human chronic myelogenous leukemia |
NL8502929A (nl) * | 1985-10-25 | 1987-05-18 | Tno | Groep viii-overgangsmetaal-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijke groep viii-overgangsmetaal-complex voor de behandeling van kanker, alsmede aldus verkregen gevormd geneesmiddel. |
US5759837A (en) | 1989-01-17 | 1998-06-02 | John Hopkins University | Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway |
CN1061908A (zh) | 1991-12-21 | 1992-06-17 | 江西省妇产医院 | 一种治癌药物的制造方法 |
CN1060935C (zh) | 1992-05-31 | 2001-01-24 | 丛繁滋 | 用于癌病灶直接给药的砷制剂的制备方法 |
CN1044777C (zh) | 1992-07-06 | 1999-08-25 | 杨世泽 | 癌痛止痛膏的配制方法 |
DK0651636T3 (da) | 1992-07-24 | 2003-01-27 | Univ Johns Hopkins | Kemoterapi for cancer |
FR2699820B3 (fr) * | 1992-12-24 | 1995-03-10 | Eric Pichot | Traitement homéopathique préventif des dysmytoses (cancer, leucémie) et malformations ou mutations génétiques. |
DE4317331A1 (de) * | 1993-05-25 | 1994-12-01 | Reischle Karl Georg | Behandlung von Schädigungen des Immunsystems |
ITTO930510A1 (it) | 1993-07-09 | 1993-10-07 | Walter Tarello | Farmaci attivi contro la chronic fatigue syndrome (c.f.s.) |
US5889048A (en) | 1994-02-18 | 1999-03-30 | Vorobieva; Tamara Vasilievna | Methods and compositions for treating defective cell functions |
US5626862A (en) * | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
CN1119113A (zh) | 1994-09-22 | 1996-03-27 | 衣永德 | 复方癌复康胶囊及制备方法 |
CN1122700A (zh) | 1994-11-08 | 1996-05-22 | 付知中 | 一种治疗乳腺疾病、肿瘤疮毒的散剂及其制备方法 |
LV11667B (en) * | 1995-08-14 | 1997-06-20 | Tamara Vorobieva | Remedy for renewal of disordered function of immunomodulation and cell tissue reproduction adjustors |
CN1044559C (zh) | 1995-08-23 | 1999-08-11 | 哈尔滨医科大学附属第一医院 | 抗白血病、肝癌、淋巴瘤注射液 |
US5748699A (en) * | 1995-10-06 | 1998-05-05 | Smith; Donald O. | Apparatus for applying X-rays to an interior surface of a body cavity |
CN1058620C (zh) | 1995-11-12 | 2000-11-22 | 卢颖 | 一种治疗癌症的外用中成药及配备生产工艺 |
CN1052648C (zh) | 1995-12-03 | 2000-05-24 | 唐书生 | 癌瘤消肿止痛膏 |
EP1964557B1 (en) * | 1997-11-10 | 2013-01-02 | Memorial Sloan-Kettering Cancer Center | Process for producing arsenic trioxide formulations |
CN1233476A (zh) | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
MXPA05003161A (es) * | 2002-09-24 | 2005-09-12 | Novartis Ag | Uso de derivados de 4-piridil-metil-ftalazina para la fabricacion de un medicamento para el tratamiento de sindromes mielodisplasticos. |
US20050196464A1 (en) * | 2004-03-03 | 2005-09-08 | Tty Biopharm Company Limited | Method and pharmaceutical composition for treatment of skin neoplasm |
-
1998
- 1998-10-15 AU AU10893/99A patent/AU751932B2/en not_active Expired
- 1998-10-15 IL IL13562098A patent/IL135620A0/xx unknown
- 1998-10-15 BR BR9813085-4A patent/BR9813085A/pt not_active IP Right Cessation
- 1998-10-15 DK DK03019628T patent/DK1391206T3/da active
- 1998-10-15 PL PL98339909A patent/PL339909A1/xx unknown
- 1998-10-15 AT AT03019594T patent/ATE407683T1/de active
- 1998-10-15 WO PCT/US1998/021782 patent/WO1999018798A1/en not_active Application Discontinuation
- 1998-10-15 DE DE69839682T patent/DE69839682D1/de not_active Expired - Lifetime
- 1998-10-15 EP EP03019629A patent/EP1378241A1/en not_active Withdrawn
- 1998-10-15 EP EP05077338A patent/EP1621077B1/en not_active Expired - Lifetime
- 1998-10-15 ES ES03019594T patent/ES2312701T3/es not_active Expired - Lifetime
- 1998-10-15 DE DE69840006T patent/DE69840006D1/de not_active Expired - Lifetime
- 1998-10-15 PT PT08016665T patent/PT2018858E/pt unknown
- 1998-10-15 AT AT05077338T patent/ATE409043T1/de active
- 1998-10-15 EP EP04007847A patent/EP1466607A1/en not_active Ceased
- 1998-10-15 DK DK03019594T patent/DK1378240T3/da active
- 1998-10-15 US US09/173,531 patent/US6875451B2/en not_active Expired - Lifetime
- 1998-10-15 EP EP08016665A patent/EP2018858B1/en not_active Expired - Lifetime
- 1998-10-15 JP JP2000515442A patent/JP2001519366A/ja active Pending
- 1998-10-15 CN CN98812218A patent/CN1282218A/zh active Pending
- 1998-10-15 ES ES03019628T patent/ES2309258T3/es not_active Expired - Lifetime
- 1998-10-15 KR KR1020007003973A patent/KR20010015755A/ko not_active Application Discontinuation
- 1998-10-15 DK DK08016665.5T patent/DK2018858T3/da active
- 1998-10-15 PT PT05077338T patent/PT1621077E/pt unknown
- 1998-10-15 EP EP03019628A patent/EP1391206B1/en not_active Expired - Lifetime
- 1998-10-15 ES ES05077338T patent/ES2313201T3/es not_active Expired - Lifetime
- 1998-10-15 NZ NZ503973A patent/NZ503973A/en unknown
- 1998-10-15 EP EP03029713A patent/EP1419778A1/en not_active Ceased
- 1998-10-15 EP EP03019594A patent/EP1378240B1/en not_active Expired - Lifetime
- 1998-10-15 CA CA002307208A patent/CA2307208A1/en not_active Abandoned
- 1998-10-15 EP EP03019595A patent/EP1374875A3/en not_active Withdrawn
- 1998-10-15 EP EP98953552A patent/EP1022951A4/en not_active Withdrawn
- 1998-10-15 TR TR2000/01959T patent/TR200001959T2/xx unknown
- 1998-10-15 DE DE69842094T patent/DE69842094D1/de not_active Expired - Lifetime
- 1998-10-15 DE DE69840057T patent/DE69840057D1/de not_active Expired - Lifetime
- 1998-10-15 ES ES08016665T patent/ES2358624T3/es not_active Expired - Lifetime
- 1998-10-15 DK DK05077338T patent/DK1621077T3/da active
- 1998-10-15 PT PT03019594T patent/PT1378240E/pt unknown
- 1998-10-15 AT AT03019628T patent/ATE399560T1/de active
- 1998-10-15 PT PT03019628T patent/PT1391206E/pt unknown
- 1998-10-15 AT AT08016665T patent/ATE493979T1/de active
-
2000
- 2000-04-14 NO NO20001977A patent/NO20001977L/no not_active Application Discontinuation
-
2001
- 2001-01-29 HK HK04104293.2A patent/HK1061199A1/xx not_active IP Right Cessation
- 2001-01-29 HK HK04104292A patent/HK1061198A1/xx not_active IP Right Cessation
-
2003
- 2003-08-14 US US10/640,399 patent/US7163703B2/en not_active Expired - Lifetime
- 2003-08-14 US US10/640,403 patent/US7132116B2/en not_active Expired - Lifetime
- 2003-08-28 US US10/649,944 patent/US20040047916A1/en not_active Abandoned
- 2003-08-28 US US10/649,776 patent/US7179493B2/en not_active Expired - Lifetime
- 2003-11-03 US US10/698,625 patent/US7205001B2/en not_active Expired - Lifetime
-
2004
- 2004-02-12 US US10/776,504 patent/US20040161475A1/en not_active Abandoned
- 2004-02-27 US US10/789,604 patent/US20040197420A1/en not_active Abandoned
- 2004-02-27 US US10/789,628 patent/US20040197421A1/en not_active Abandoned
-
2006
- 2006-07-25 HK HK06108235.2A patent/HK1085886A1/xx not_active IP Right Cessation
-
2008
- 2008-09-24 CY CY20081101031T patent/CY1108363T1/el unknown
- 2008-12-02 CY CY20081101395T patent/CY1110055T1/el unknown
- 2008-12-10 CY CY20081101430T patent/CY1110057T1/el unknown
-
2011
- 2011-04-05 CY CY20111100361T patent/CY1111379T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111379T1 (el) | Συνθεσεις και μεθοδοι για τη θεραπευτικη αντιμετωπιση πρωτογενων και μεταστατικων-νεοπλασματικων ασθενειων με τη χρηση τριοξειδιου του αρσενικου | |
IL150767A (en) | Benzophyrene compounds and their use in the manufacture of drugs for the treatment of estrogen-sensitive diseases such as endometrial cancer | |
ATE243692T1 (de) | Arylaminderivate und ihre verwendung als antitelomerasemittel | |
WO2000018439A3 (de) | Verwendung von neoangiogenese-markern für diagnose und therapie von tumoren | |
DE60027870D1 (de) | Genetische manipulierte herpesviren zur behandlung von tumoren | |
ATE121622T1 (de) | Verfahren zur sensibilisierung von tumorzellen. | |
BR0215689A (pt) | Composição farmacêutica compreendendo arsênico para o tratamento de malignidade | |
ATE306255T1 (de) | 19-nor-vitamin d3 derivate mit calciumspiegel erhöhender wirkung | |
AU5302599A (en) | Method for diagnosing bone metastasis of malignant tumor | |
DE60212415D1 (de) | Die verwendung von einer 4-pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren | |
ID16885A (id) | Stimulasi mekanisme pertahanan pejamu melawan tumor. | |
ATE247467T1 (de) | Neue therapeutische verwendung von 1,6-dimethyl- 8beta-hydroxymethyl-10alpha-methoxyergolin | |
DE60235085D1 (de) | Herstellungsverfahren von derivate von bisphosphonaten | |
MX9701832A (es) | Nuevos profarmacos para la terapia de tumores y enfermedades inflamatorias. |